Julie Nonnekens

Company: Erasmus MC Cancer Institute

Job title: Associate Professor

Seminars:

Panel Discussion: Phase 0 for Radiopharmaceuticals: Benefits & Risks 1:30 pm

Showcasing various preclinical studies (in vitro and in vivo) Addressing different combination treatments of 177Lu-based radionuclide therapies and agents such as DNA damage repair inhibitors Discussing cellular mechanisms and how to use this knowledge to design future (clinical) combination studiesRead more

day: Day 2 C&S Track Pm